165 related articles for article (PubMed ID: 36434041)
1. The deubiquitinating enzyme STAMBP is a newly discovered driver of triple-negative breast cancer progression that maintains RAI14 protein stability.
Yang Q; Yan D; Zou C; Xue Q; Lin S; Huang Q; Li X; Tang D; Chen X; Liu J
Exp Mol Med; 2022 Nov; 54(11):2047-2059. PubMed ID: 36434041
[TBL] [Abstract][Full Text] [Related]
2. The expression and clinical significance of STAMBP in breast cancer.
Li L; Yang X; He M; Xu X; Xuan X; Zhang J; Zhang L; Xu H; Li D
Mol Biol Rep; 2023 Jan; 50(1):899-906. PubMed ID: 36309616
[TBL] [Abstract][Full Text] [Related]
3. STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway.
Xu H; Yang X; Xuan X; Wu D; Zhang J; Xu X; Zhao Y; Ma C; Li D
Neoplasia; 2021 Jun; 23(6):607-623. PubMed ID: 34102455
[TBL] [Abstract][Full Text] [Related]
4. STAM-binding protein regulates melanoma metastasis through SLUG stabilization.
Iwakami Y; Yokoyama S; Watanabe K; Hayakawa Y
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):484-488. PubMed ID: 30454887
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis.
Liu S; González-Prieto R; Zhang M; Geurink PP; Kooij R; Iyengar PV; van Dinther M; Bos E; Zhang X; Le Dévédec SE; van de Water B; Koning RI; Zhu HJ; Mesker WE; Vertegaal ACO; Ovaa H; Zhang L; Martens JWM; Ten Dijke P
Clin Cancer Res; 2020 Mar; 26(6):1460-1473. PubMed ID: 31857432
[TBL] [Abstract][Full Text] [Related]
6. VGLL4 interacts with STAT3 to function as a tumor suppressor in triple-negative breast cancer.
Song H; Luo Q; Deng X; Ji C; Li D; Munankarmy A; Jian W; Zhao J; Fang L
Exp Mol Med; 2019 Nov; 51(11):1-13. PubMed ID: 31748508
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1.
Guo Y; Liu Q; Mallette E; Caba C; Hou F; Fux J; LaPlante G; Dong A; Zhang Q; Zheng H; Tong Y; Zhang W
J Biol Chem; 2021 Oct; 297(4):101107. PubMed ID: 34425109
[TBL] [Abstract][Full Text] [Related]
8. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
9. STAM binding protein regulated by hsa_circ_0007334 exerts oncogenic potential in pancreatic cancer.
Yu S; E C; Yang J
Pancreatology; 2022 Nov; 22(7):1003-1012. PubMed ID: 36089485
[TBL] [Abstract][Full Text] [Related]
10. USP10 promotes the progression of triple-negative breast cancer by enhancing the stability of TCF4 protein.
Yang JR; Lu YB; Su HX; Xiao Y; Pan Q; Su F; Zhang XB; Zhu KL; Guan QL; Ling XL
Biochem Pharmacol; 2023 Dec; 218():115864. PubMed ID: 37863330
[TBL] [Abstract][Full Text] [Related]
11. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
Ding L; Xie Z
Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
[TBL] [Abstract][Full Text] [Related]
12. S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cells.
Kikuchi K; McNamara KM; Miki Y; Iwabuchi E; Kanai A; Miyashita M; Ishida T; Sasano H
Cell Oncol (Dordr); 2019 Feb; 42(1):67-80. PubMed ID: 30244410
[TBL] [Abstract][Full Text] [Related]
13. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
14. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
Guo GC; Wang JX; Han ML; Zhang LP; Li L
Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
[TBL] [Abstract][Full Text] [Related]
15. BTF3 promotes stemness and inhibits TypeⅠInterferon signaling pathway in triple-negative breast cancer.
Wang H; Gao L; Qi M; Su P; Xiong X; Zhao J; Hu J; Han B
Biochem Biophys Res Commun; 2021 Jan; 537():22-28. PubMed ID: 33383560
[TBL] [Abstract][Full Text] [Related]
16. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
Han C; Li X; Fan Q; Liu G; Yin J
Aging (Albany NY); 2019 Jul; 11(14):4858-4875. PubMed ID: 31310241
[TBL] [Abstract][Full Text] [Related]
17. CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1.
Lin Y; Zhang J; Li Y; Guo W; Chen L; Chen M; Chen X; Zhang W; Jin X; Jiang M; Xiao H; Wang C; Song C; Fu F
J Transl Med; 2022 Jan; 20(1):17. PubMed ID: 34991621
[TBL] [Abstract][Full Text] [Related]
18. miR-122-5p promotes aggression and epithelial-mesenchymal transition in triple-negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen-activated protein kinase signaling.
Wang Z; Wang X
J Cell Physiol; 2020 Mar; 235(3):2825-2835. PubMed ID: 31541468
[TBL] [Abstract][Full Text] [Related]
19. The dual-crosslinked prospective values of RAI14 for the diagnosis and chemosurveillance in triple negative breast cancer.
Cui R; Zou J; Zhao Y; Zhao T; Ren L; Li Y
Ann Med; 2023 Dec; 55(1):820-836. PubMed ID: 36880986
[TBL] [Abstract][Full Text] [Related]
20. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]